首页> 外文期刊>Annals of Saudi medicine. >Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency
【24h】

Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency

机译:高剂量钙化固醇与单次大剂量麦角钙化固醇进行10天疗程在纠正维生素D缺乏症中的作用

获取原文
           

摘要

BACKGROUND AND OBJECTIVES:?The correction of vitamin D deficiency is crucial for optimal skeletal and non-skeletal health. Most regimens in current use are based on daily dosing, which may raise concerns of dosage inadequacy and suboptimal patient compliance. Vitamin D is available in 2 forms: D2 (ergocalciferol) and D3 (cholecalciferol). It has been reported that D2 supplements are less effective and may enhance the degradation of 25-hydroxyvitamin D3 (25[OH]D3) metabolite. The aim of this study was to compare the effect of 2 high-dose oral vitamin D regimens—a 10-day course of D3 500000 IU versus a single mega dose of 600000 IU D2—on serum 25(OH)D levels. DESIGN AND SETTINGS: A prospective cohort study was conducted from September 2010 to February 2011 in an urban university tertiary hospital in Amman, Jordan. PATIENTS AND METHODS: A total of 109 patients aged 18 to 79 years were enrolled with severe vitamin D deficiency. Fifty-one subjects received 600000 IU D2 orally and 54 subjects received a total dose of 500000 IU D3 administered orally, as 50000 IU D3 daily for 10 consecutive days. Baseline and follow-up total serum 25(OH)D, 25(OH)D2, and 25(OH)D3 levels were compared. RESULTS:?The mean total 25(OH)D increment from baseline was 10.33 (5.68) ng/mL over a mean of 43.08 (2.81) days for the D2 group. The mean increment in 25(OH)D for the D3 group was 47.03 (23.67) ng/mL over a mean of 36.9 (2.9) days. The difference between the 2 mean increments was highly significant: P =3.15.10-18. The 600 000 IU D2 single mega-dose decreased 25(OH)D3 levels by an average of 4 ng/mL in 37 subjects. CONCLUSION:?Overall, the 10-day oral D3 regimen rapidly and effectively normalized 25(OH)D levels. The shortened dosing interval over 10 consecutive days might result in higher compliance.
机译:背景和目的:维生素D缺乏症的纠正对最佳骨骼和非骨骼健康至关重要。当前使用的大多数方案都是基于每日剂量的,这可能引起对剂量不足和患者依从性欠佳的担忧。维生素D有2种形式:D2(麦角钙化醇)和D3(胆固醇钙化醇)。据报道,D2补充剂效果较差,可能会增强25-羟基维生素D3(25 [OH] D3)代谢产物的降解。这项研究的目的是比较两种高剂量口服维生素D疗法(D3 500000 IU的10天疗程和单剂量600000 IU D2的大剂量疗法)对血清25(OH)D水平的影响。设计与地点:前瞻性队列研究于2010年9月至2011年2月在约旦安曼的一家城市大学三级医院进行。患者与方法:共有109位年龄在18至79岁的患者患有严重的维生素D缺乏症。 51名受试者口服600000 IU D2,54名受试者口服总剂量500000 IU D3,连续10天每天服用50000 IU D3。比较基线和随访总血清25(OH)D,25(OH)D2和25(OH)D3的水平。结果:D2组在平均43.08(2.81)天的时间内,从基线开始的平均25(OH)D总增量为10.33(5.68)ng / mL。 D3组的25(OH)D平均增加量为47.03(23.67)ng / mL,平均36.9(2.9)天。 2个平均增量之间的差异非常显着:P = 3.15.10-18。 600 000 IU D2单剂量在37位受试者中使25(OH)D3水平平均降低了4 ng / mL。结论:总体而言,为期10天的口服D3方案可快速有效地使25(OH)D水平正常化。连续10天的服药间隔缩短可能会导致更高的依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号